These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. An abnormal distribution of delta F508 genotypes in cystic fibrosis patient registries. Feingold J; Guilloud-Bataille M; De Crozes D Ann Genet; 1998; 41(1):31-3. PubMed ID: 9599649 [TBL] [Abstract][Full Text] [Related]
24. [Interference of P1290 P polymorphism (4002 A--> G) in molecular diagnosis of mucoviscidosis using the cystic fibrosis assay: an example of a diagnostic trap]. Bienvenu T; Bousquet S; Souville I; Beldjord C Ann Biol Clin (Paris); 1999; 57(6):741-2. PubMed ID: 10572229 [No Abstract] [Full Text] [Related]
29. Distribution of 9 common mutations in the CFTR gene in Slovak cystic fibrosis patients. Kádasi L; Poláková H; Zatková A; Kayserová H Gene Geogr; 1997 Apr; 11(1):51-6. PubMed ID: 9615214 [TBL] [Abstract][Full Text] [Related]
30. Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia. Banjar H East Mediterr Health J; 1999 Nov; 5(6):1230-5. PubMed ID: 11924117 [TBL] [Abstract][Full Text] [Related]
32. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Rodman DM; Polis JM; Heltshe SL; Sontag MK; Chacon C; Rodman RV; Brayshaw SJ; Huitt GA; Iseman MD; Saavedra MT; Taussig LM; Wagener JS; Accurso FJ; Nick JA Am J Respir Crit Care Med; 2005 Mar; 171(6):621-6. PubMed ID: 15591474 [TBL] [Abstract][Full Text] [Related]
33. [Identification of mutation in the gene cystic fibrosis transmembrane regulator (CFTR) in Chilean patients with cystic fibrosis]. Repetto G; Poggi H; Harris P; Navarro H; Sánchez I; Guiraldes E; Pérez MA; Boza ML; Hunter B; Wevar ME; Mediavilla M; Foradori A Rev Med Chil; 2001 Aug; 129(8):841-7. PubMed ID: 11680956 [TBL] [Abstract][Full Text] [Related]
34. [Genetic counseling in cystic fibrosis]. Julia S; Bieth E Rev Mal Respir; 2000 Aug; 17(3 Pt 2):807-11. PubMed ID: 11076391 [TBL] [Abstract][Full Text] [Related]
35. N1303K and IVS8-5T, clinical presentation within a family with atypical cystic fibrosis. Van Hoorenbeeck K; Storm K; van den Ende J; Biervliet M; Desager KN J Cyst Fibros; 2007 May; 6(3):220-2. PubMed ID: 17127107 [TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of northwestern Mexican patients with cystic fibrosis: screening of 10 known mutations. Mutations in brief no. 185. Online. Flores-Martínez SE; Dean M; Saiki RK; Gallegos-Arreola MP; Morán-Moguel MC; Sánchez-Corona J Hum Mutat; 1998; 12(3):217-8. PubMed ID: 10660336 [TBL] [Abstract][Full Text] [Related]
37. Novel CFTR mutations in a Korean infant with cystic fibrosis and pancreatic insufficiency. Choe YJ; Ko JS; Seo JK; Han JJ; Shim JO; Koh YY; Lee R; Ki CS; Kim JW; Kim JH J Korean Med Sci; 2010 Jan; 25(1):163-5. PubMed ID: 20052365 [TBL] [Abstract][Full Text] [Related]
39. [Mucoviscidosis discovered after the age of 25 years. Review and follow-up of cases of the literature]. Pescatore P; Marteau P; Lemière E; Xerri B; Denamur E; Elion J; Matuchansky C; Rambaud JC Gastroenterol Clin Biol; 1994; 18(3):195-9. PubMed ID: 7926432 [TBL] [Abstract][Full Text] [Related]
40. Pancreatic Insufficiency in a Child with p.Gly542* and c.2657+5G>A Heterozygote CFTR: A Case Report. Dos Anjos F; Wruck J; do Carmo TIT; Miranda Soares VE; de Resende E Silva DT; Bagatini MD; de Oliveira Maciel SFV Clin Med Res; 2022 Mar; 20(1):46-51. PubMed ID: 35131845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]